193 related articles for article (PubMed ID: 15206730)
1. Kynurenine metabolism in central nervous system in experimental chronic renal failure.
Topczewska-Bruns J; Pawlak D; Tankiewicz A; Chabielska E; Buczko W
Adv Exp Med Biol; 2003; 527():177-82. PubMed ID: 15206730
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan metabolism via the kynurenine pathway in experimental chronic renal failure.
Pawlak D; Tankiewicz A; Mysliwiec P; Buczko W
Nephron; 2002 Mar; 90(3):328-35. PubMed ID: 11867954
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
Int Urol Nephrol; 2001; 33(2):399-404. PubMed ID: 12092667
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine and its metabolites in the rat with experimental renal insufficiency.
Pawlak D; Tankiewicz A; Buczko W
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):755-66. PubMed ID: 11785771
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of 3-hydroxykynurenine in different brain regions of rats with chronic renal insufficiency.
Topczewska-Bruns J; Pawlak D; Chabielska E; Tankiewicz A; Buczko W
Brain Res Bull; 2002 Aug; 58(4):423-8. PubMed ID: 12183021
[TBL] [Abstract][Full Text] [Related]
6. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure.
Pawlak D; Tankiewicz A; Matys T; Buczko W
J Physiol Pharmacol; 2003 Jun; 54(2):175-89. PubMed ID: 12832720
[TBL] [Abstract][Full Text] [Related]
7. Species differences in L-tryptophan-kynurenine pathway metabolism: quantification of anthranilic acid and its related enzymes.
Fujigaki S; Saito K; Takemura M; Fujii H; Wada H; Noma A; Seishima M
Arch Biochem Biophys; 1998 Oct; 358(2):329-35. PubMed ID: 9784247
[TBL] [Abstract][Full Text] [Related]
8. Kidney and liver kynurenine pathway enzymes in chronic renal failure.
Tankiewicz A; Pawlak D; Topczewska-Bruns J; Buczko W
Adv Exp Med Biol; 2003; 527():409-14. PubMed ID: 15206758
[TBL] [Abstract][Full Text] [Related]
9. Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2
Forrest CM; Kennedy PG; Rodgers J; Dalton RN; Turner C; Darlington LG; Cobb SR; Stone TW
Neurochem Int; 2016 Nov; 100():110-119. PubMed ID: 27623092
[TBL] [Abstract][Full Text] [Related]
10. A single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma.
Orsatti L; Speziale R; Orsale MV; Caretti F; Veneziano M; Zini M; Monteagudo E; Lyons K; Beconi M; Chan K; Herbst T; Toledo-Sherman L; Munoz-Sanjuan I; Bonelli F; Dominguez C
J Pharm Biomed Anal; 2015 Mar; 107():426-31. PubMed ID: 25668794
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to methyl mercury in rats: focus on changes in kynurenine pathway.
Zanoli P; Cannazza G; Baraldi M
Brain Res Bull; 2001 May; 55(2):235-8. PubMed ID: 11470321
[TBL] [Abstract][Full Text] [Related]
13. [Tryptophan and its metabolites in renal allograft recipients].
Myśliwiec P; Myśliwiec H; Pawlak D; Dadan J; Buczko W; Pawlak K
Przegl Lek; 2009; 66(3):115-8. PubMed ID: 19689033
[TBL] [Abstract][Full Text] [Related]
14. An exploratory study of the interplay between decreased concentration of tryptophan, accumulation of kynurenines, and inflammatory arthritis.
Kolodziej L
IUBMB Life; 2012 Dec; 64(12):983-7. PubMed ID: 23124849
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease may evoke anxiety by altering CRH expression in the amygdala and tryptophan metabolism in rats.
Ibos KE; Bodnár É; Dinh H; Kis M; Márványkövi F; Kovács ZZA; Siska A; Földesi I; Galla Z; Monostori P; Szatmári I; Simon P; Sárközy M; Csabafi K
Pflugers Arch; 2024 Feb; 476(2):179-196. PubMed ID: 37989901
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B
Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289
[TBL] [Abstract][Full Text] [Related]
17. Quantification of anthranilic acid and its related enzyme activity in several different species.
Fujigaki S; Saito K; Fujii H; Wada H; Seishima M
Adv Exp Med Biol; 1999; 467():625-8. PubMed ID: 10721110
[TBL] [Abstract][Full Text] [Related]
18. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
[TBL] [Abstract][Full Text] [Related]
19. Evidence that kynurenine pathway metabolites mediate hyperbaric oxygen-induced convulsions.
Dale WE; Dang Y; Amiridze N; Brown OR
Toxicol Lett; 2000 Sep; 117(1-2):37-43. PubMed ID: 11033231
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan metabolism in the central nervous system: medical implications.
Ruddick JP; Evans AK; Nutt DJ; Lightman SL; Rook GA; Lowry CA
Expert Rev Mol Med; 2006 Aug; 8(20):1-27. PubMed ID: 16942634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
